NCT07638644

Brief Summary

The goal of this clinical trial is to find out which method works best to reduce pain after braces are adjusted for the first time (when the first archwire is placed). The study will compare three approaches: acupressure (applying pressure on a specific point on the hand), ibuprofen (a pain-relief medicine), and chewing sugar-free gum. It will also check how safe these methods are and whether patients need extra pain medicine. The main questions the researchers want to answer are: Which method reduces orthodontic pain the most after the first archwire is placed? Do patients need extra painkillers in any of the groups? Are there any problems with braces (such as loose brackets or wire issues) within the first week? Researchers will compare the three groups to see which option gives the best pain relief during the first few days after braces are activated. Participants will: Be placed into one of three groups: acupressure, ibuprofen, or chewing gum Use their assigned method after their first orthodontic wire is placed Rate their pain at different time points using a simple pain scale (VAS) Report if they take any extra pain medicine Be checked for any brace-related problems for up to 7 days This study may help improve comfort and pain management for patients starting orthodontic treatment.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started Jul 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 10, 2026

Completed
21 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

June 11, 2026

Status Verified

June 1, 2026

Enrollment Period

7 months

First QC Date

June 5, 2026

Last Update Submit

June 9, 2026

Conditions

Keywords

Post-archwire orthodontic painFixed orthodontic treatmentChewing gum pain reliefIbuprofen analgesiaAcupressure LI4 Hegu point

Outcome Measures

Primary Outcomes (1)

  • Post-archwire orthodontic pain

    Pain experienced by patients following placement of the initial orthodontic archwire, measured using the Visual Analog Scale (VAS).

    Pain levels will be recorded using a 10-cm visual analog scale (vas) at the following intervals: • 2 hours • 6 hours • Bedtime (day 1) • 24 hours (day 2) • Day 3 • Day 7

Secondary Outcomes (2)

  • Rescue analgesic consumption

    Within 7 days following initial archwire placement.

  • Appliance-related complications

    Within 7 days following initial archwire placement.

Study Arms (3)

Acupressure Intervention

EXPERIMENTAL

Participants in this arm will receive instructions on the use of acupressure for orthodontic pain management following placement of the initial archwire. Verbal instructions and a standardized advice sheet will be provided. Participants will be trained to apply steady, perpendicular pressure using the thumb of the opposite hand to the LI4 (Hegu) acupressure point for approximately 3 minutes. The location of the LI4 point will be demonstrated and identified as the point on the dorsum of the hand between the first and second metacarpal bones, at the midpoint of the second metacarpal bone near its radial border. Participants will be instructed to perform acupressure according to the standardized study protocol.

Behavioral: Acupressure

Ibuprofen Intervention

ACTIVE COMPARATOR

In the ibuprofen group participants will be provided with a 400 mg oral dose post arch wire placement. With a minimum gap of 8 hours between doses, remaining doses will be taken as per need for the relief of pain with the total daily dose not surpassing 1200 mg.

Drug: Ibuprofen 400 mg (if necessary)

Chewing Gum Intervention

EXPERIMENTAL

Instructions to chew sugar-free gum for a period of 10 minutes immediately post arch wire placement will be provided to the chewing gum group, 8 hourly, for pain relief.

Behavioral: Chewing Gum

Interventions

AcupressureBEHAVIORAL

Participants in this arm will receive instructions on the use of acupressure for orthodontic pain management following placement of the initial archwire. Verbal instructions and a standardized advice sheet will be provided. Participants will be trained to apply steady, perpendicular pressure using the thumb of the opposite hand to the LI4 (Hegu) acupressure point for approximately 3 minutes. The location of the LI4 point will be demonstrated and identified as the point on the dorsum of the hand between the first and second metacarpal bones, at the midpoint of the second metacarpal bone near its radial border. Participants will be instructed to perform acupressure according to the standardized study protocol.

Also known as: LI4 (Hegu) Acupressure
Acupressure Intervention

In the ibuprofen group participants will be provided with a 400 mg oral dose post arch wire placement. With a minimum gap of 8 hours between doses, remaining doses will be taken as per need for the relief of pain with the total daily dose not surpassing 1200 mg.

Ibuprofen Intervention
Chewing GumBEHAVIORAL

Instructions to chew sugar-free gum for a period of 10 minutes immediately post arch wire placement will be provided to the chewing gum group, 8 hourly, for pain relief.

Chewing Gum Intervention

Eligibility Criteria

Age15 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 15 to 35 years
  • Complete permanent dentition
  • Undergoing comprehensive fixed orthodontic treatment
  • Scheduled for initial archwire placement
  • Ability to comply with study procedures
  • Written informed consent provided (or parental/guardian consent for participants younger than 18 years)

You may not qualify if:

  • Pregnant or lactating
  • Systemic disorders that may affect pain perception
  • Periodontal disease
  • Neurological abnormalities that may affect pain perception
  • Known sensitivity to chewing gum
  • Documented allergy to ibuprofen
  • Use of adjunctive orthodontic appliances
  • Use of analgesics, anti-inflammatory medications, or other medications that may affect pain perception within 24 hours before enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Malocclusion

Interventions

AcupressureIbuprofenChewing Gum

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Therapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitationPhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsPlant GumsBiopolymersPolymersMacromolecular SubstancesPolysaccharidesCarbohydratesPlant ExudatesBiological ProductsComplex MixturesCandyFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of three parallel groups: acupressure, ibuprofen, or chewing gum. Each group will receive a different intervention following placement of the initial orthodontic archwire, and outcomes will be assessed independently without crossover between groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 5, 2026

First Posted

June 10, 2026

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

June 11, 2026

Record last verified: 2026-06